RxDoctor Payments Data

Fredrick Melik-Abrahamian

Emergency Medicine · Sylmar, CANPI 1134159890

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $291,565 of the $353,963 with a category attached, or 82.4%. Grifols USA, LLC accounts for 73.0% of it on its own, with 4 other manufacturers making up the rest. Among emergency medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$353,963in general payments, 2019–2025

Across 575 payments — averaging $615.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Grifols USA, LLC$258K
  • AbbVie$89K
  • Paratek Pharmaceuticals, Inc.$6K
  • Medicure Pharma Inc.$667
  • AstraZeneca$125

What the payments were for

  • Consulting fees$3,2301%
  • Speaking & faculty fees$291,56582%
  • Travel & lodging$46,88913%
  • Food & beverage$12,2793%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Grifols USA, LLC391$258,482
AbbVie(2 entities)174$88,657
Paratek Pharmaceuticals, Inc.7$6,033
Medicure Pharma Inc.2$667
AstraZeneca1$125

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$353,963 in reported general payments places this provider in the 95th percentile of 6,006 emergency medicine providers in California.

See all emergency medicine providers in California

Other emergency medicine in Sylmar

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →